Trinseo SA (TSE)
Official siteSPECIALTY CHEMICALS
Last updated: Nov 13, 2026 at 4:00 PM ET
Trinseo SA (TSE) Financials: Revenue, Profit and Cash Flow
Trinseo SA reported revenue of $2.97B for the fiscal year ended Dec 31, 2025, down 15.3% from the year before. That year, net income was -$545.60M with a net margin of -18.3%, operating cash flow was -$102.40M and free cash flow was -$153.40M. The quarter ended Mar 31, 2026 had revenue of $724.70M and net income of -$115.90M.
Revenue and Margins
The operating margin was -8.4% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $3.72B, a compound annual decline of 2.5%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.97B | -15.3% | 5.6% | -8.4% | -18.3% |
| Dec 2024 | $3.51B | -4.4% | 7.6% | -1.3% | -9.9% |
| Dec 2023 | $3.68B | -26.0% | 3.9% | -12.4% | -19.1% |
| Dec 2022 | $4.97B | +2.9% | 5.5% | -7.3% | -8.7% |
| Dec 2021 | $4.83B | +75.9% | 14.5% | 9.6% | 9.1% |
| Dec 2020 | $2.74B | -18.7% | 11.7% | 5.5% | 0.3% |
| Dec 2019 | $3.37B | -27.0% | 8.9% | 4.2% | 2.7% |
| Dec 2018 | $4.62B | +3.9% | 11.4% | 9.0% | 6.3% |
| Dec 2017 | $4.45B | +19.7% | 14.7% | 12.1% | 7.4% |
| Dec 2016 | $3.72B | N/A | 15.8% | 13.4% | 8.6% |
Income Statement
In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Mar 2026, the net loss widened from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.97B | $3.51B | $3.68B | $4.97B | $4.83B | $2.74B | $3.37B | $4.62B | $4.45B | $3.72B |
| Cost of revenue | $2.81B | $3.25B | $3.53B | $4.69B | $4.13B | $2.42B | $3.07B | $4.09B | $3.79B | $3.13B |
| Gross profit | $165.90M | $265.60M | $142.30M | $272.30M | $698.90M | $321.10M | $300.40M | $528.80M | $654.00M | $587.63M |
| Research and development | $0 | $0 | $57.60M | $51.40M | $63.90M | $42.60M | $54.60M | $56.00M | $51.90M | $51.00M |
| Operating income | -$251.10M | -$46.00M | -$455.40M | -$363.90M | $461.40M | $149.60M | $142.50M | $414.40M | $538.70M | $498.20M |
| Net income | -$545.60M | -$348.50M | -$701.30M | -$430.90M | $440.00M | $7.90M | $92.00M | $292.50M | $328.30M | $318.31M |
| EBITDA | -$251.10M | $159.70M | -$223.30M | -$119.80M | $597.40M | $241.60M | $230.60M | $540.60M | $593.00M | $583.10M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $724.70M | $662.60M | $743.20M | $784.30M | $784.80M | $821.50M | $867.70M | $920.00M | $904.00M | $837.50M | $879.00M | $962.60M |
| Gross profit | $61.70M | $28.10M | $37.40M | $36.60M | $63.80M | $56.00M | $80.60M | $68.40M | $60.60M | $20.30M | $31.30M | $53.60M |
| Operating income | -$25.70M | -$160.60M | -$28.20M | -$33.30M | -$29.00M | -$44.20M | -$12.40M | $13.90M | -$3.30M | -$72.00M | -$16.40M | -$336.80M |
| Net income | -$115.90M | -$251.40M | -$109.70M | -$105.50M | -$79.00M | -$117.90M | -$87.30M | -$67.80M | -$75.50M | -$265.00M | -$38.40M | -$349.00M |
Balance Sheet
As of Dec 2025, total debt of $2.56B exceeded cash and equivalents by $2.41B. Shareholder equity was negative, at -$1.10B, as total liabilities of $3.38B exceeded total assets of $2.28B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.28B | $2.64B | $3.03B | $3.76B | $4.71B | $2.85B | $2.76B | $2.73B | $2.77B | $2.42B |
| Current assets | $864.70M | $988.20M | $1.19B | $1.39B | $1.98B | $1.52B | $1.49B | $1.63B | $1.65B | $1.43B |
| Cash and equivalents | $146.70M | $209.80M | $259.10M | $211.70M | $573.00M | $588.70M | $456.20M | $452.30M | $432.80M | $465.11M |
| Total liabilities | $3.38B | $3.26B | $3.30B | $3.34B | $3.70B | $2.25B | $2.09B | $1.96B | $2.10B | $1.96B |
| Short-term debt | $224.50M | $223.80M | $37.20M | $33.10M | $36.90M | $27.70M | $25.20M | $7.00M | $7.00M | $5.00M |
| Long-term debt | $2.33B | $2.20B | $2.28B | $2.30B | $2.31B | $1.16B | $1.16B | $1.16B | $1.17B | $1.16B |
| Shareholder equity | -$1.10B | -$619.90M | -$268.00M | $420.30M | $1.01B | $590.30M | $668.90M | $768.70M | $674.80M | $445.05M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.31B | $2.28B | $2.49B | $2.63B | $2.65B | $2.64B | $2.88B | $2.85B | $2.99B | $3.03B | $3.27B | $3.35B |
| Total liabilities | $3.53B | $3.38B | $3.35B | $3.38B | $3.33B | $3.26B | $3.36B | $3.26B | $3.34B | $3.30B | $3.29B | $3.33B |
| Cash and equivalents | $110.60M | $146.70M | $112.10M | $137.00M | $126.10M | $209.80M | $165.30M | $105.60M | $166.40M | $259.10M | $278.60M | $269.50M |
| Shareholder equity | -$1.22B | -$1.10B | -$861.60M | -$750.30M | -$679.20M | -$619.90M | -$480.00M | -$413.80M | -$348.00M | -$268.00M | -$21.40M | $21.20M |
Cash Flow
Operating cash flow was negative in the fiscal year ended Dec 2025.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$102.40M | -$22.80M | $125.30M | $43.50M | $452.70M | $255.40M | $322.50M | $366.50M | $391.30M | $403.66M |
| Capital expenditures | $51.00M | $63.30M | $69.70M | $148.20M | $117.70M | $82.30M | $110.10M | $121.40M | $147.40M | $123.87M |
| Free cash flow | -$153.40M | -$86.10M | $55.60M | -$104.70M | $335.00M | $173.10M | $212.40M | $245.10M | $243.90M | $279.79M |
| Dividends paid | $1.20M | $1.70M | $17.90M | $47.50M | $21.90M | $61.80M | $65.70M | $66.00M | $58.00M | $27.30M |
| Investing cash flow | -$41.00M | -$55.10M | -$31.70M | -$164.00M | -$1.54B | -$24.20M | -$109.30M | -$118.70M | -$182.60M | -$117.30M |
| Financing cash flow | $73.50M | $35.00M | -$42.60M | -$233.70M | $1.08B | -$104.30M | -$206.70M | -$222.20M | -$253.00M | -$247.54M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | N/A | -$210.55M | -$21.60M | $6.80M | -$110.20M | $85.10M | $8.80M | -$42.17M | -$66.20M | $17.50M | $29.30M | $56.50M |
| Capital expenditures | $11.30M | $25.80M | $16.50M | $9.80M | $8.70M | $21.20M | $12.20M | $14.08M | $15.70M | $20.60M | $13.50M | $13.80M |
| Free cash flow | N/A | -$236.35M | -$38.10M | -$3.00M | -$118.90M | $63.90M | -$3.40M | -$56.25M | -$81.90M | -$3.10M | $15.80M | $42.70M |
Frequently Asked Questions About TSE
What is Trinseo SA's annual revenue?
Trinseo SA reported revenue of $2.97B for the fiscal year ended Dec 31, 2025.
How fast is Trinseo SA's revenue growing?
Revenue was down 15.3% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -15.7%.
Is Trinseo SA profitable?
No. Trinseo SA reported net income of -$545.60M for the fiscal year ended Dec 31, 2025, with a net margin of -18.3%.
How much free cash flow does TSE generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of -$102.40M minus capital expenditures of $51.00M produced free cash flow of -$153.40M.
How much debt does Trinseo SA have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.33B, short-term debt of $224.50M and cash and equivalents of $146.70M.
TSE pages: Overview, Financials